Annual Accounts Payable
$3.83 M
+$2.73 M+249.27%
31 December 2023
Summary:
CymaBay Therapeutics annual accounts payable is currently $3.83 million, with the most recent change of +$2.73 million (+249.27%) on 31 December 2023. During the last 3 years, it has risen by +$1.10 million (+40.32%).CBAY Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$3.83 M
+$1.10 M+40.17%
31 December 2023
Summary:
CymaBay Therapeutics quarterly accounts payable is currently $3.83 million, with the most recent change of +$1.10 million (+40.17%) on 31 December 2023.CBAY Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBAY Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +40.3% | +40.3% |
| 5 y5 years | +52.9% | +52.9% |
CBAY Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | -16.6% |
CymaBay Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $3.83 M(+249.3%) | $3.83 M(+40.2%) |
| Sept 2023 | - | $2.73 M(-40.5%) |
| June 2023 | - | $4.59 M(+181.0%) |
| Mar 2023 | - | $1.63 M(+49.0%) |
| Dec 2022 | $1.10 M(-59.8%) | $1.10 M(+128.8%) |
| Sept 2022 | - | $479.00 K(-44.7%) |
| June 2022 | - | $866.00 K(+335.2%) |
| Mar 2022 | - | $199.00 K(-92.7%) |
| Dec 2021 | $2.73 M(+1081.0%) | $2.73 M(+257.1%) |
| Sept 2021 | - | $764.00 K(-27.2%) |
| June 2021 | - | $1.05 M(-34.6%) |
| Mar 2021 | - | $1.61 M(+595.2%) |
| Dec 2020 | $231.00 K(-90.8%) | $231.00 K(-75.6%) |
| Sept 2020 | - | $947.00 K(+98.9%) |
| June 2020 | - | $476.00 K(-60.8%) |
| Mar 2020 | - | $1.21 M(-51.5%) |
| Dec 2019 | $2.50 M(+26.9%) | $2.50 M(+67.5%) |
| Sept 2019 | - | $1.49 M(-48.2%) |
| June 2019 | - | $2.88 M(+19.6%) |
| Mar 2019 | - | $2.41 M(+22.1%) |
| Dec 2018 | $1.97 M | $1.97 M(+21.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $1.63 M(+21.9%) |
| June 2018 | - | $1.34 M(-34.4%) |
| Mar 2018 | - | $2.04 M(+55.5%) |
| Dec 2017 | $1.31 M(+45.8%) | $1.31 M(+6.2%) |
| Sept 2017 | - | $1.24 M(+12.2%) |
| June 2017 | - | $1.10 M(+0.5%) |
| Mar 2017 | - | $1.10 M(+21.9%) |
| Dec 2016 | $899.00 K(-10.8%) | $899.00 K(-3.9%) |
| Sept 2016 | - | $935.00 K(-26.5%) |
| June 2016 | - | $1.27 M(-28.4%) |
| Mar 2016 | - | $1.78 M(+76.3%) |
| Dec 2015 | $1.01 M(-51.7%) | $1.01 M(+42.6%) |
| Sept 2015 | - | $707.00 K(-58.9%) |
| June 2015 | - | $1.72 M(+12.7%) |
| Mar 2015 | - | $1.53 M(-26.8%) |
| Dec 2014 | $2.08 M(+199.1%) | $2.08 M(+99.1%) |
| Sept 2014 | - | $1.05 M(-17.0%) |
| June 2014 | - | $1.26 M(+18.1%) |
| Mar 2014 | - | $1.07 M(+53.4%) |
| Dec 2013 | $697.00 K(+6.1%) | $697.00 K |
| Dec 2012 | $657.00 K | - |
FAQ
- What is CymaBay Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for CymaBay Therapeutics?
- What is CymaBay Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for CymaBay Therapeutics?
What is CymaBay Therapeutics annual accounts payable?
The current annual accounts payable of CBAY is $3.83 M
What is the all time high annual accounts payable for CymaBay Therapeutics?
CymaBay Therapeutics all-time high annual accounts payable is $3.83 M
What is CymaBay Therapeutics quarterly accounts payable?
The current quarterly accounts payable of CBAY is $3.83 M
What is the all time high quarterly accounts payable for CymaBay Therapeutics?
CymaBay Therapeutics all-time high quarterly accounts payable is $4.59 M